Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5206289
Max Phase: Preclinical
Molecular Formula: C21H32O3
Molecular Weight: 332.48
Associated Items:
ID: ALA5206289
Max Phase: Preclinical
Molecular Formula: C21H32O3
Molecular Weight: 332.48
Associated Items:
Canonical SMILES: CC1(C)CCC[C@]2(C)[C@@H](Cc3cccc(O)c3O)[C@](C)(O)CC[C@@H]12
Standard InChI: InChI=1S/C21H32O3/c1-19(2)10-6-11-20(3)16(19)9-12-21(4,24)17(20)13-14-7-5-8-15(22)18(14)23/h5,7-8,16-17,22-24H,6,9-13H2,1-4H3/t16-,17+,20-,21+/m0/s1
Standard InChI Key: IPOOIBGLKSWLQF-KJNZLNQQSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 332.48 | Molecular Weight (Monoisotopic): 332.2351 | AlogP: 4.63 | #Rotatable Bonds: 2 |
Polar Surface Area: 60.69 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 9.53 | CX Basic pKa: | CX LogP: 4.78 | CX LogD: 4.78 |
Aromatic Rings: 1 | Heavy Atoms: 24 | QED Weighted: 0.69 | Np Likeness Score: 2.30 |
1. Wang X, Hu N, Kong W, Song B, Li S.. (2022) Facile and divergent optimization of chromazonarol enabled the identification of simplified drimane meroterpenoids as novel pharmaceutical leads., 227 [PMID:34653771] [10.1016/j.ejmech.2021.113912] |
Source(1):